| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
Molecular Biology, Pathobiology, and Genetics |
1 Division of Comparative Medicine and 2 Center for Environmental Health Sciences, Massachusetts Institute of Technology, Cambridge, Massachusetts
Requests for reprints: Arlin Rogers, Division of Comparative Medicine 16-849, Massachusetts Institute of Technology, Cambridge, MA 02139. Phone: 617-253-9442; Fax: 617-252-1882; E-mail: abr{at}mit.edu.
Hepatocellular carcinoma (HCC) is a male-predominant cancer associated with chronic hepatitis. Like human viral hepatitis, murine Helicobacter hepaticus infection produces inflammation and HCC with a masculine bias. We used this model to identify potential mechanisms of male HCC predisposition. Male weanling A/JCr mice (n = 67) were gavaged with H. hepaticus or vehicle. At 1 year, mice were distributed into four groups: surgical castration, chemical castration, castration followed by dihydrotestosterone supplementation, or sexually intact controls. Responses to infection were compared with IFN-
challenge alone. At 21 months, there was no significant difference in hepatitis between groups. Neither castration nor androgen receptor agonism altered tumor incidence. Infected mice with severe, but not mild, disease exhibited a mosaic of alterations to sexually dimorphic genes and microsomal long-chain fatty acids. By microarray, tumorigenic hepatitis was strongly associated with liver-gender disruption, defined as the loss of a gender-identifying hepatic molecular signature. IFN-
alone produced similar changes, demonstrating a role for proinflammatory cytokines in this process. In conclusion, hepatocarcinogenesis in male mice with chronic hepatitis is maturationally imprinted and androgen-independent. Proinflammatory cytokines may promote HCC in a male-predominant fashion due to high sensitivity of the masculinized liver to loss of sex-specific transcriptional balance. Liver-gender disruption has pleiotropic implications for hepatic enzyme activity, lipid processing, nuclear receptor activation, apoptosis, and proliferation. We propose a multistep model linking chronic hepatitis to liver cancer through cytokine-mediated derangement of gender-specific cellular metabolism. This model introduces a novel mechanism of inflammation-associated carcinogenesis consistent with male-predominant HCC risk. [Cancer Res 2007;67(24):11536–46]
This article has been cited by other articles:
![]() |
J. Ji, J. Shi, A. Budhu, Z. Yu, M. Forgues, S. Roessler, S. Ambs, Y. Chen, P. S. Meltzer, C. M. Croce, et al. MicroRNA Expression, Survival, and Response to Interferon in Liver Cancer N. Engl. J. Med., October 8, 2009; 361(15): 1437 - 1447. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. J. Waxman and M. G. Holloway Sex Differences in the Expression of Hepatic Drug Metabolizing Enzymes Mol. Pharmacol., August 1, 2009; 76(2): 215 - 228. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. J. Krebs, S. Khan, J. W. MacDonald, M. Sorenson, and D. M. Robins Regulator of sex-limitation KRAB zinc finger proteins modulate sex-dependent and -independent liver metabolism Physiol Genomics, June 10, 2009; 38(1): 16 - 28. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. B. Lemke, Z. Ge, M. T. Whary, Y. Feng, A. B. Rogers, S. Muthupalani, and J. G. Fox Concurrent Helicobacter bilis Infection in C57BL/6 Mice Attenuates Proinflammatory H. pylori-Induced Gastric Pathology Infect. Immun., May 1, 2009; 77(5): 2147 - 2158. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. J. Theve, Y. Feng, K. Taghizadeh, K. S. Cormier, D. R. Bell, J. G. Fox, and A. B. Rogers Sex Hormone Influence on Hepatitis in Young Male A/JCr Mice Infected with Helicobacter hepaticus Infect. Immun., September 1, 2008; 76(9): 4071 - 4078. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Garcia, M. M. Ihrig, R. C. Fry, Y. Feng, S. Xu, S. R. Boutin, A. B. Rogers, S. Muthupalani, L. D. Samson, and J. G. Fox Genetic Susceptibility to Chronic Hepatitis Is Inherited Codominantly in Helicobacter hepaticus-Infected AB6F1 and B6AF1 Hybrid Male Mice, and Progression to Hepatocellular Carcinoma Is Linked to Hepatic Expression of Lipogenic Genes and Immune Function-Associated Networks Infect. Immun., May 1, 2008; 76(5): 1866 - 1876. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Cancer Research | Clinical Cancer Research |
| Cancer Epidemiology Biomarkers & Prevention | Molecular Cancer Therapeutics |
| Molecular Cancer Research | Cancer Prevention Research |
| Cancer Prevention Journals Portal | Cancer Reviews Online |
| Annual Meeting Education Book | Meeting Abstracts Online |